Skip Navigation


European Heart Journal Advance Access originally published online on October 2, 2006
European Heart Journal 2006 27(23):2900; doi:10.1093/eurheartj/ehl295
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/23/2900    most recent
ehl295v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scheen, A. J.
Right arrow Articles by Legrand, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheen, A. J.
Right arrow Articles by Legrand, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Aspirin and clopidogrel resistance in patients with diabetes mellitus

André J. Scheen

Division of Diabetes, Nutrition, and Metabolic Disorders
Department of Medicine
CHU Sart Tilman (B35)
University of Liège
B-4000 Liège
Belgium
Tel.: +32 4 3667238
Fax: +32 4 3667068
E-mail address: andre.scheen@chu.ulg.ac.be

Delphine Legrand

Division of Diabetes, Nutrition, and Metabolic Disorders
Department of Medicine
CHU Sart Tilman
University of Liège
B-4000 Liège
Belgium

The first 10% of the full text of this article appears below.

We read with interest the review paper on aspirin and clopidogrel resistance by Wang et al.1 We agree that it is an emerging entity with important clinical implications. Nevertheless, we were surprised that very little emphasis was put on the antiplatelet agent resistance of diabetic patients. Only one . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?